N

NewLimit

17 employees

NewLimit is creating epigenetic reprogramming medications to cure diseases with significant unmet medical needs.

Basic info

Industry

biotechnology research

Sectors

Clinical Trials
Biotechnology
Health Care

Date founded

2022

Funding rounds raised

Total raised

$40M

from 3 investors over 3 rounds

N

NewLimit raised $40M on May 16, 2023

Investors: Founders Fund, Dimension and Kleiner Perkins

FAQ